These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 14634456)
21. Spontaneous and prostatic steroid binding protein peptide-induced autoimmune prostatitis in the nonobese diabetic mouse. Penna G; Amuchastegui S; Cossetti C; Aquilano F; Mariani R; Giarratana N; De Carli E; Fibbi B; Adorini L J Immunol; 2007 Aug; 179(3):1559-67. PubMed ID: 17641022 [TBL] [Abstract][Full Text] [Related]
22. Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy. Liu KJ; Chatta GS; Twardzik DR; Vedvick TS; True LD; Spies AG; Cheever MA J Immunol; 1997 Jul; 159(1):472-80. PubMed ID: 9200488 [TBL] [Abstract][Full Text] [Related]
24. Production of reactive nitrogen intermediates (RNI) by peritoneal macrophages from rats with experimental autoimmune prostatitis (EAP). Orsilles MA; Depiante-Depaoli M Inflammation; 1995 Aug; 19(4):415-22. PubMed ID: 7558247 [TBL] [Abstract][Full Text] [Related]
25. Activation of cytotoxic cells by syngeneic prostate antigens in experimental autoimmune vesiculo-prostatitis. Casas-Ingaramo A; Depiante-Depaoli M; Pacheco-Rupil B Autoimmunity; 1991; 9(2):151-7. PubMed ID: 1932521 [TBL] [Abstract][Full Text] [Related]
26. Prolactin influences upon androgen action in male accessory sex organs. Thomas JA; Keenan EJ Adv Sex Horm Res; 1976; 2():425-70. PubMed ID: 189591 [TBL] [Abstract][Full Text] [Related]
27. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio. Yatkin E; Bernoulli J; Talvitie EM; Santti R Int J Androl; 2009 Aug; 32(4):399-410. PubMed ID: 19515173 [TBL] [Abstract][Full Text] [Related]
28. Six transmembrane epithelial antigen of the prostate 1 is down-regulated by sex hormones in prostate cells. Gomes IM; Santos CR; Socorro S; Maia CJ Prostate; 2013 May; 73(6):605-13. PubMed ID: 23060075 [TBL] [Abstract][Full Text] [Related]
29. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response. Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716 [TBL] [Abstract][Full Text] [Related]
30. Inflammatory cells and MHC class II antigens expression in prostate during time-course experimental autoimmune prostatitis development. Donadio AC; Depiante-Depaoli M Clin Immunol Immunopathol; 1997 Nov; 85(2):158-65. PubMed ID: 9344698 [TBL] [Abstract][Full Text] [Related]
31. Effect of prolactin on the metabolism of androgens by the rat ventral prostate gland in vitro. Manandhar MS; Thomas JA Invest Urol; 1976 Jul; 14(1):20-2. PubMed ID: 955845 [TBL] [Abstract][Full Text] [Related]
32. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen. Geller J J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965 [TBL] [Abstract][Full Text] [Related]
33. Age-related alterations in inflammatory response during experimental autoimmune prostatitis. Morón G; Maletto B; Orsilles M; Depiante-Depaoli M; Pistoresi-Palencia MC Mech Ageing Dev; 2000 Sep; 118(1-2):71-85. PubMed ID: 10989126 [TBL] [Abstract][Full Text] [Related]
34. Prostatein (or rat prostatic steroid binding protein) is a major autoantigen in experimental autoimmune prostatitis. Maccioni M; Rivero VE; Riera CM Clin Exp Immunol; 1998 May; 112(2):159-65. PubMed ID: 9649176 [TBL] [Abstract][Full Text] [Related]
35. Impact of vitamin D receptor activity on experimental autoimmune prostatitis. Motrich RD; van Etten E; Depovere J; Riera CM; Rivero VE; Mathieu C J Autoimmun; 2009 Mar; 32(2):140-8. PubMed ID: 19269787 [TBL] [Abstract][Full Text] [Related]
36. Chronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: Effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain. Kurita M; Yamaguchi H; Okamoto K; Kotera T; Oka M Prostate; 2018 Nov; 78(15):1157-1165. PubMed ID: 30009466 [TBL] [Abstract][Full Text] [Related]
37. Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation. Nunlist EH; Dozmorov I; Tang Y; Cowan R; Centola M; Lin HK J Steroid Biochem Mol Biol; 2004 Jul; 91(3):157-70. PubMed ID: 15276623 [TBL] [Abstract][Full Text] [Related]
38. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer. Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491 [TBL] [Abstract][Full Text] [Related]
39. Time course of reactive oxygen intermediates release and histopathological findings during experimental autoimmune prostatitis development. Orsilles MA; Donadio AC; Depiante-Depaoli M Prostate; 1995 Jul; 27(1):50-7. PubMed ID: 7603914 [TBL] [Abstract][Full Text] [Related]
40. Androgen biosynthetic pathways in the human prostate. Luu-The V; Bélanger A; Labrie F Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):207-21. PubMed ID: 18471780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]